肺功能是生存的门吗? - FEV1Q和COPD和慢性呼吸衰竭患者的死亡率
Filip Björklund1, Andreas Palm2, Josefin Sundh3
1Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Respiratory Medicine, Allergology, and Palliative Medicine, Lund, Sweden.
Respiratory medicine
|July 4, 2025
概括
FEV1指数 (FEV1Q) 显示了COPD患者死亡风险的人口值. 然而,FEV1Q和FEV1预测的百分比对于预测个体死亡风险并不有用.
科学领域:
- 肺部医学 肺部医学
- 呼吸系统生理学 呼吸系统生理学
- 临床流行病学临床流行病学
背景情况:
- FEV1 分数 (FEV1Q) 是一种新的肺功能指标.
- 它在慢性呼吸衰竭和与死亡率相关的有用性是未知的.
研究的目的:
- 为了研究FEV1Q在依赖氧气的慢性肺炎中的适用性.
- 为了确定FEV1Q与死亡率之间的连续关联.
主要方法:
- 对DISCOVERY数据库进行纵向分析.
- 使用Cox和Fine-Gray模型预测FEV1Q和FEV1%预测死亡率的比较.
- 使用受限立方线的连续关联的评估.
主要成果:
- 在5,711名COPD患者中,较高的FEV1Q与较低的整体和呼吸道死亡风险相关.
- 预测FEV1Q和FEV1的百分比显示出相同的预测能力 (C-统计值0.60).
- 观察到一个J形关联,低于FEV1Q<1.0的死亡风险增加.
结论:
- 在FEV1Q水平<1.0.0时,确定了增加死亡风险的人口值.
- 无论FEV1Q还是FEV1 %-预测都不是个体患者死亡率的有用预测指标.
相关概念视频
Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
Respiratory Capacities
888
Respiratory capacities are crucial indicators of lung function, representing the maximum amount of air an individual's respiratory system can handle during various breathing phases.
One key metric is the Inspiratory Capacity (IC), which represents the maximum amount of air that can be inhaled with full effort. IC is calculated by summing the tidal volume and inspiratory reserve volume, typically ranging from 2.4 to 3.6 liters.
The Functional Residual Capacity (FRC) represents the air in the...
One key metric is the Inspiratory Capacity (IC), which represents the maximum amount of air that can be inhaled with full effort. IC is calculated by summing the tidal volume and inspiratory reserve volume, typically ranging from 2.4 to 3.6 liters.
The Functional Residual Capacity (FRC) represents the air in the...
888
Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
Acute Respiratory Failure-III
332
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
332
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
COPD: Management Using Bronchodilators and Corticosteroids
322
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
322


